Work

Outcome and immune landscape of HER2-positive invasive lobular carcinoma in the North Central Cancer Treatment Group (NCCTG) N9831 (Alliance) trial.

Year: 2021

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2021.39.15_suppl.535

Authors: Saranya Chumsri, Zhuo Li, Tracy Shachner, Pooja Advani, Kostandinos Sideras, Alvaro Moreno-Aspitia, Gerardo Colon-Otero, Keith L. Knutson, Aziza Nassar, Edith A. Perez, E Aubrey Thompson

Institutions: Mayo Clinic in Florida, Erasmus MC

Language: English

Topic: Breast Cancer Treatment Studies

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3167229981

Cites:

Cited by: 5

Related to: 10